InnovAge (INNV) Competitors

Addus HomeCare (NASDAQ:ADUS) and InnovAge (NASDAQ:INNV) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their community ranking, valuation, institutional ownership, dividends, earnings, profitability, media sentiment, analyst recommendations and risk.

Does the media prefer ADUS or INNV?

In the previous week, Addus HomeCare had 10 more articles in the media than InnovAge. MarketBeat recorded 13 mentions for Addus HomeCare and 3 mentions for InnovAge. InnovAge's average media sentiment score of 1.01 beat Addus HomeCare's score of 0.85 indicating that InnovAge is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Addus HomeCare	8 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
InnovAge	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts recommend ADUS or INNV?

Addus HomeCare currently has a consensus price target of $142.57, suggesting a potential upside of 28.10%. InnovAge has a consensus price target of $5.00, suggesting a potential upside of 23.61%. Given Addus HomeCare's stronger consensus rating and higher possible upside, equities research analysts clearly believe Addus HomeCare is more favorable than InnovAge.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Addus HomeCare	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	3.25
InnovAge	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Which has higher valuation and earnings, ADUS or INNV?

Addus HomeCare has higher revenue and earnings than InnovAge. InnovAge is trading at a lower price-to-earnings ratio than Addus HomeCare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Addus HomeCare	$1.21B	1.69	$62.52M	$4.43	25.12
InnovAge	$831.68M	0.66	-$21.34M	-$0.23	-17.59

Does the MarketBeat Community prefer ADUS or INNV?

Addus HomeCare received 332 more outperform votes than InnovAge when rated by MarketBeat users. Likewise, 69.02% of users gave Addus HomeCare an outperform vote while only 0.00% of users gave InnovAge an outperform vote.

Company	Underperform	Outperform
Addus HomeCare	Outperform Votes 332 69.02%	Underperform Votes 149 30.98%
InnovAge	Outperform Votes No Votes	Underperform Votes 5 100.00%

Which has more volatility and risk, ADUS or INNV?

Addus HomeCare has a beta of 0.85, meaning that its stock price is 15% less volatile than the S&P 500. Comparatively, InnovAge has a beta of 0.4, meaning that its stock price is 60% less volatile than the S&P 500.

Do insiders & institutionals believe in ADUS or INNV?

95.3% of Addus HomeCare shares are held by institutional investors. Comparatively, 12.3% of InnovAge shares are held by institutional investors. 4.6% of Addus HomeCare shares are held by company insiders. Comparatively, 1.4% of InnovAge shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Is ADUS or INNV more profitable?

Addus HomeCare has a net margin of 6.50% compared to InnovAge's net margin of -3.19%. Addus HomeCare's return on equity of 9.62% beat InnovAge's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Addus HomeCare	6.50%	9.62%	7.37%
InnovAge	-3.19%	-9.45%	-4.84%

Summary

Addus HomeCare beats InnovAge on 18 of the 19 factors compared between the two stocks.